No abstract available
Keywords:
Melanoma; PD-1; cancer immunotherapy; pembrolizumab; safety.
MeSH terms
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Humans
-
Melanoma / drug therapy*
-
Skin Neoplasms / drug therapy*
Substances
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
pembrolizumab